Zhida Liu Selected Research

Inflammasomes

1/2021

The AIM2 and NLRP3 inflammasomes trigger IL-1-mediated antitumor effects during radiation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhida Liu Research Topics

Disease

29	Neoplasms (Cancer) 12/2023 - 01/2016
4	Bites and Stings (Sting) 01/2022 - 01/2019
2	Infections 12/2023 - 01/2020
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2019
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 02/2024
1	COVID-19 12/2023
1	Neoplasm Metastasis (Metastasis) 11/2023
1	Adenocarcinoma of Lung 01/2022
1	Inflammation (Inflammations) 01/2021
1	Triple Negative Breast Neoplasms 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Idiopathic Pulmonary Fibrosis 12/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2017
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2016
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2015

Drug/Important Bio-Agent (IBA)

7	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2016
5	VaccinesIBA 01/2023 - 06/2016
5	AntigensIBA 01/2022 - 06/2016
3	Interleukin-2 (IL2)IBA 01/2021 - 01/2019
3	B7-H1 AntigenIBA 01/2021 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2019
3	InterferonsIBA 01/2021 - 01/2019
3	Therapeutic UsesIBA 01/2020 - 01/2016
2	Messenger RNA (mRNA)IBA 12/2023 - 12/2023
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 12/2023 - 01/2023
2	ProdrugsIBA 01/2023 - 01/2019
2	NanovaccinesIBA 01/2022 - 01/2019
2	Interferon Type IIBA 01/2022 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 12/2018
2	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 01/2020
2	Peptides (Polypeptides)IBA 01/2021 - 01/2019
2	Caspase 9IBA 11/2020 - 01/2020
2	Complement System Proteins (Complement)IBA 01/2020 - 01/2017
1	Carbon DioxideIBA 02/2024
1	ethyleneIBA 12/2023
1	Phosphates (Orthophosphate)IBA 12/2023
1	Broadly Neutralizing AntibodiesIBA 12/2023
1	AntibodiesIBA 12/2023
1	Singlet OxygenIBA 01/2023
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2023
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Cancer VaccinesIBA 01/2022
1	Protons (Proton)IBA 01/2022
1	InflammasomesIBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	EnzymesIBA 01/2021
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2021
1	CaspasesIBA 01/2020
1	Mitochondrial DNA (mtDNA)IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 10/2019
1	Cetuximab (Erbitux)FDA Link 10/2019
1	NAD (NADH)IBA 01/2019
1	Oxidoreductases (Dehydrogenase)IBA 01/2019
1	Ferritins (Ferritin)IBA 01/2019
1	Polysaccharides (Glycans)IBA 01/2019
1	DisaccharidesIBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2019
1	HMGB1 Protein (HMG1)IBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	beta-lapachoneIBA 01/2019
1	quinone (benzoquinone)IBA 01/2019
1	dioleoyl-N-(monomethoxypolyethylene glycol succinyl)phosphatidylethanolamineIBA 01/2017
1	MicellesIBA 01/2017
1	PlatinumIBA 03/2015
1	Ifosfamide FDA LinkGeneric 03/2015
1	Etoposide (VP 16)FDA LinkGeneric 03/2015

Therapy/Procedure

14	Immunotherapy 12/2023 - 01/2016
12	Therapeutics 01/2022 - 01/2016
4	Radiotherapy 01/2021 - 01/2016
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2016
1	Continuous Renal Replacement Therapy 02/2024
1	Artificial Respiration (Mechanical Ventilation) 02/2024
1	Intravenous Administration 12/2023
1	Subcutaneous Injections 01/2022
1	Precision Medicine 01/2022
1	Radioimmunotherapy 01/2021